143 related articles for article (PubMed ID: 28838457)
1. Coexistent End-stage Nonalcoholic Steatohepatitis and Colon Cancer: Should We Do Liver Transplantation?
Aliyev V; Yasuchika K; Hammad A; Badawy A; Nigmet Y; Tajima T; Fukumitsu K; Yagi S; Hata K; Okajima H; Uemoto S
Transplant Proc; 2017 Sep; 49(7):1649-1651. PubMed ID: 28838457
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India.
Kumar S; Khandelwal N; Kumar A; Yadav K; Sharma S; Sable S; Chauhan A; Kapoor S; Varma V; Palep J; Kumaran V
Indian J Gastroenterol; 2017 May; 36(3):243-247. PubMed ID: 28560633
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
4. A Single-Center Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Recurrence in Recipients of Liver Transplant for Treatment of Nonalcoholic Steatohepatitis Cirrhosis.
Matsuoka L; Chotai PN; Slaughter J; Campbell K; Kerr A; Hamel S; Garza C; Alexopoulos SP; Scanga A
Exp Clin Transplant; 2022 Feb; 20(2):150-156. PubMed ID: 35037605
[TBL] [Abstract][Full Text] [Related]
5. Outcome of liver transplantation in patients with prior bariatric surgery.
Safwan M; Collins KM; Abouljoud MS; Salgia R
Liver Transpl; 2017 Nov; 23(11):1415-1421. PubMed ID: 28752920
[TBL] [Abstract][Full Text] [Related]
6. How can we treat a patient with liver cirrhosis (hepatitis C virus), hepatocellular carcinoma, and synchronous colon cancer?
Antoniou E; Mantas D; Paraskeva P; Dimitroulis D; Smyrnis A; Nikitakis N; Labadariou A; Tsavaris N; Vernicos P; Kostakis A
Transplant Proc; 2012 Nov; 44(9):2745-7. PubMed ID: 23146511
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
Patel YA; Berg CL; Moylan CA
Dig Dis Sci; 2016 May; 61(5):1406-16. PubMed ID: 26815171
[TBL] [Abstract][Full Text] [Related]
8. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
Siddiqui MS; Charlton M
Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation with dual grafts -- a case report.
Botea F; Braşoveanu V; Constantinescu A; Ionescu M; Matei E; Popescu I
Chirurgia (Bucur); 2013; 108(4):547-52. PubMed ID: 23958100
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
11. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
Flemming JA; Kim WR; Brosgart CL; Terrault NA
Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
[TBL] [Abstract][Full Text] [Related]
12. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
13. Pediatric liver transplantation.
Cuenca AG; Kim HB; Vakili K
Semin Pediatr Surg; 2017 Aug; 26(4):217-223. PubMed ID: 28964477
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
Piazza NA; Singal AK
Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival with growth hormone replacement after liver transplantation of pediatric nonalcoholic steatohepatitis complicating acquired hypopituitarism.
Fujio A; Kawagishi N; Echizenya T; Tokodai K; Nakanishi C; Miyagi S; Sato K; Fujimori K; Ohuchi N
Tohoku J Exp Med; 2015 Jan; 235(1):61-7. PubMed ID: 25744617
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of Patients Following Liver Transplant From Deceased and Living Donors.
Yesmembetov K; Sultanaliyev T; Mukazhanov A; Zhexembayev A; Kuttymuratov G; Spatayev Z; Mussin Y; Umbetzhanov Y; Orazbayeva D
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):152-153. PubMed ID: 29528015
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
[TBL] [Abstract][Full Text] [Related]
18. Liver and kidney transplant in primary hyperoxaluria: a single center experience.
Moray G; Tezcaner T; Özçay F; Baskın E; Akdur A; Kırnap M; Yıldırım S; Arslan G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():145-7. PubMed ID: 25894144
[TBL] [Abstract][Full Text] [Related]
19. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
20. Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.
Bhati C; Idowu MO; Sanyal AJ; Rivera M; Driscoll C; Stravitz RT; Kohli DR; Matherly S; Puri P; Gilles H; Cotterell A; Levy M; Sterling RK; Luketic VA; Lee H; Sharma A; Siddiqui MS
Transplantation; 2017 Aug; 101(8):1867-1874. PubMed ID: 28296807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
